R. Friedman

CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer’s Disease

P. Davies, V. Vingtdeux, J. Koppel, 2013, Molecular Medicine.

Cardiovascular responses to combined treatment with selective monoamine oxidase type B inhibitors and L‐DOPA in the rat

M. Youdim, J. Finberg, O. Bar‐Am, 2006, British journal of pharmacology.

Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease.

Wei Huang, David Lerner, Sandor Molnar, 2002, Journal of medicinal chemistry.

CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer’s Disease

P. Davies, V. Vingtdeux, J. Koppel, 2014, Molecular medicine.

Cardiovascular baroreceptor activity and selective inhibition of monoamine oxidase.

A. Gross, J. Finberg, R. Friedman, 2012, European journal of pharmacology.

CB 2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer ’ s Disease

P. Davies, V. Vingtdeux, J. Koppel, 2014 .